Literature DB >> 8017169

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.

I Moroo1, T Yamada, H Makino, I Tooyama, P L McGeer, E G McGeer, K Hirayama.   

Abstract

Immunohistochemistry using both a newly developed polyclonal, and a commercially available monoclonal, anti-insulin receptor antibody was done on the midbrain from cases of idiopathic Parkinson's disease (PD), Alzheimer's disease, amyotrophic lateral sclerosis, vascular parkinsonism and non-neurological controls. Both antibodies gave identical patterns of neuronal staining. The neurons of the oculomotor nucleus were immunopositive in all the brains. However, the neurons in the pars compacta of the substantia nigra, paranigral nucleus, parabrachial pigmental nucleus, tegmental pedunculopontine nucleus, supratrocheal nucleus, cuneiform nucleus, subcuneiform nucleus and lemniscus medialis, which were positive in other diseases and in non-neurological controls, were not stained by these antibodies in PD brains. These results suggest that, in PD, a dysfunction of the insulin/insulin receptor system may precede death of the dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017169     DOI: 10.1007/bf00313602

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Basic fibroblast growth factor enhances survival and sprouting of fetal dopaminergic cells implanted in the denervated rat caudate-putamen: preliminary observations.

Authors:  H W Steinbusch; R J Vermeulen; J A Tonnaer
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

Review 2.  Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects.

Authors:  J W Unger; J N Livingston; A M Moss
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

3.  Purification and characterization of the human brain insulin receptor.

Authors:  R A Roth; D O Morgan; J Beaudoin; V Sara
Journal:  J Biol Chem       Date:  1986-03-15       Impact factor: 5.157

4.  Localization of 125I-insulin binding sites in the rat hypothalamus by quantitative autoradiography.

Authors:  E S Corp; S C Woods; D Porte; D M Dorsa; D P Figlewicz; D G Baskin
Journal:  Neurosci Lett       Date:  1986-09-25       Impact factor: 3.046

5.  Stimulation of synaptosomal uptake of neurotransmitter amino acids by insulin: possible role of insulin as a neuromodulator.

Authors:  D E Rhoads; R J DiRocco; L D Osburn; N A Peterson; E Raghupathy
Journal:  Biochem Biophys Res Commun       Date:  1984-03-30       Impact factor: 3.575

6.  The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling.

Authors:  Y Ebina; L Ellis; K Jarnagin; M Edery; L Graf; E Clauser; J H Ou; F Masiarz; Y W Kan; I D Goldfine
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

7.  Insulin dependent neurite outgrowth in cultured embryonic mouse brain cells.

Authors:  N R Bhat
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

8.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes.

Authors:  A Ullrich; J R Bell; E Y Chen; R Herrera; L M Petruzzelli; T J Dull; A Gray; L Coussens; Y C Liao; M Tsubokawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

Review 9.  The insulin receptor. A multifunctional protein.

Authors:  J M Olefsky
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

10.  Reduction of food intake and body weight by chronic intraventricular insulin infusion.

Authors:  D J Brief; J D Davis
Journal:  Brain Res Bull       Date:  1984-05       Impact factor: 4.077

View more
  43 in total

1.  Role for neuronal insulin resistance in neurodegenerative diseases.

Authors:  Markus Schubert; Dinesh Gautam; David Surjo; Kojihiko Ueki; Stephanie Baudler; Dominic Schubert; Tatsuya Kondo; Jens Alber; Norbert Galldiks; Eckehardt Küstermann; Saskia Arndt; Andreas H Jacobs; Wilhelm Krone; C Ronald Kahn; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 2.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease.

Authors:  Jose A Santiago; Judith A Potashkin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

5.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

6.  GLP-1 receptor agonists for Parkinson's disease.

Authors:  Caroline A Mulvaney; Gonçalo S Duarte; Joel Handley; David Jw Evans; Suresh Menon; Richard Wyse; Hedley Ca Emsley
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

7.  Insulin resistance impairs nigrostriatal dopamine function.

Authors:  J K Morris; G L Bomhoff; B K Gorres; V A Davis; J Kim; P-P Lee; W M Brooks; G A Gerhardt; P C Geiger; J A Stanford
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

Review 8.  Insulin receptor signaling in the development of neuronal structure and function.

Authors:  Shu-Ling Chiu; Hollis T Cline
Journal:  Neural Dev       Date:  2010-03-15       Impact factor: 3.842

Review 9.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.

Authors:  Steven E Arnold; Zoe Arvanitakis; Shannon L Macauley-Rambach; Aaron M Koenig; Hoau-Yan Wang; Rexford S Ahima; Suzanne Craft; Sam Gandy; Christoph Buettner; Luke E Stoeckel; David M Holtzman; David M Nathan
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 10.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.